000			01913 a2200541 4500
005			20250515182655.0
264		0	_c20090820
008			200908s 0 0 eng d
022			_a1538-3679
024	7		_a10.1001/archinternmed.2009.233 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, Todd A
245	0	0	_aOutcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. _h[electronic resource]
260			_bArchives of internal medicine _cAug 2009
300			_a1403-10 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdrenal Cortex Hormones _xadverse effects
650	0	4	_aAdrenergic beta-Agonists _xadverse effects
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBronchodilator Agents _xadverse effects
650	0	4	_aCause of Death
650	0	4	_aCohort Studies
650	0	4	_aDisease Progression
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProduct Surveillance, Postmarketing
650	0	4	_aProportional Hazards Models
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdiagnosis
650	0	4	_aScopolamine Derivatives _xadverse effects
650	0	4	_aSurvival Analysis
650	0	4	_aTiotropium Bromide
650	0	4	_aVeterans
700	1		_aWilke, Caitlyn
700	1		_aJoo, Min
700	1		_aStroupe, Kevin T
700	1		_aKrishnan, Jerry A
700	1		_aSchumock, Glen T
700	1		_aPickard, A Simon
773	0		_tArchives of internal medicine _gvol. 169 _gno. 15 _gp. 1403-10
856	4	0	_uhttps://doi.org/10.1001/archinternmed.2009.233 _zAvailable from publisher's website
999			_c19073624 _d19073624